{"id":1184,"date":"2024-10-08T10:56:15","date_gmt":"2024-10-08T10:56:15","guid":{"rendered":"https:\/\/lleo.es\/evaluacion-de-ashwagandha-desde-alemania\/"},"modified":"2025-05-06T08:47:37","modified_gmt":"2025-05-06T08:47:37","slug":"evaluacion-de-ashwagandha-desde-alemania","status":"publish","type":"post","link":"https:\/\/lleo.es\/en\/blog-en\/evaluacion-de-ashwagandha-desde-alemania","title":{"rendered":"Evaluation of Ashwagandha from Germany"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n

Ashwagandha, also known as\u00a0Withania somnifera<\/em>, sleep berry preparations or Indian ginseng, is an\u00a0adaptogenic plant<\/strong>\u00a0belonging to the nightshade family. It is native to India and other parts of Asia and Africa and is increasingly used in traditional medicine.<\/p>\n

Withania somnifera<\/em>\u00a0has gained popularity as a supplement due to its potential health benefits, especially in\u00a0reducing stress<\/strong>\u00a0and\u00a0anxiety<\/strong>, as well as improving\u00a0physical performance<\/strong>\u00a0and\u00a0cognitive<\/strong>\u00a0function. Ashwagandha’s bioactive compounds, known as\u00a0withanolides<\/strong>, are responsible for many of the medicinal properties attributed to the plant thanks to its anti-inflammatory, antioxidant and neuroprotective properties.<\/p>\n

Despite its broad profile of health benefits, the use of ashwagandha is currently not regulated in a harmonized way at the European level and some countries are considering the assessment of its potential health risks for specific population groups more than others.<\/p>\n

This September 2024,\u00a0Germany<\/strong>\u00a0published the opinion on ashwagandha warning against its use. The German Federal Institute for Risk Assessment (BfR) has for some time raised concerns about preparations and extracts from the root of\u00a0Withania somnifera<\/em>, recommending the entry of the plant into\u00a0Annex III of Regulation (EC) 1925\/2006 on the addition of vitamins, minerals and certain other substances to foods<\/em>. This German opinion states that the advertised\u00a0positive effects have not been scientifically proven<\/strong>\u00a0and that the risks associated with the intake of these plant preparations have not yet been adequately investigated, therefore, according to the BfR itself, the currently available data are not sufficient to allow a final risk assessment and more precise statements on health risks.<\/p>\n

It is a plant that often comes up in the Rapid Alert System for Food and Feed (RASFF) because of the different considerations for its use depending on the country, but the current studies are still insufficient for its evaluation by bodies such as EFSA and attribution of more precise official statements on health risks.<\/p>\n

From C\u00eda de Productos Naturales Lle\u00f3, we will remain attentive to any new developments in this regard.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><\/section>\n<\/div>","protected":false},"excerpt":{"rendered":"Ashwagandha, also known as\u00a0Withania somnifera, sleep berry preparations or Indian ginseng, is an\u00a0adaptogenic plant\u00a0belonging to the nightshade family. It is native to India and other parts of Asia and Africa and is increasingly used in traditional medicine. Withania somnifera\u00a0has gained popularity as a supplement due to its potential health benefits, especially in\u00a0reducing stress\u00a0and\u00a0anxiety, as well as improving\u00a0physical performance\u00a0and\u00a0cognitive\u00a0function. Ashwagandha's bioactive compounds, known as\u00a0withanolides, are responsible for many of the medicinal properties attributed to the plant thanks to its anti-inflammatory, antioxidant and neuroprotective properties. Despite its broad profile of health benefits, the use of ashwagandha is currently not regulated in a harmonized way at the European level and some countries are considering the assessment of its potential health risks for specific population groups more than others. This September 2024,\u00a0Germany\u00a0published the opinion on ashwagandha warning against its use. The German Federal Institute for Risk Assessment (BfR) has for some time raised concerns about preparations and extracts from the root of\u00a0Withania somnifera, recommending the entry of the plant into\u00a0Annex III of Regulation (EC) 1925\/2006 on the addition of vitamins, minerals and certain other substances to foods. This German opinion states that the advertised\u00a0positive effects have not been scientifically proven\u00a0and that the risks associated...","protected":false},"author":1,"featured_media":1025,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-1184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en"],"_links":{"self":[{"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/posts\/1184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/comments?post=1184"}],"version-history":[{"count":8,"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/posts\/1184\/revisions"}],"predecessor-version":[{"id":1693,"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/posts\/1184\/revisions\/1693"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/media\/1025"}],"wp:attachment":[{"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/media?parent=1184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/categories?post=1184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lleo.es\/en\/wp-json\/wp\/v2\/tags?post=1184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}